Blackstone puts $250M into Anagram to tackle cystic fibrosis complicationnews2026-05-07T15:31:33+00:00May 7th, 2026|Endpoints News|
Entrada stock falls on Duchenne data; Wegovy expands accessnews2026-05-07T15:04:25+00:00May 7th, 2026|Endpoints News|
Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germanynews2026-05-07T14:00:58+00:00May 7th, 2026|Endpoints News|
Physical chemist receives 15-year US federal research funding bannews2026-05-07T13:41:00+00:00May 7th, 2026|Chemistry World|
26 killed in fireworks factory explosion in Chinanews2026-05-07T13:34:00+00:00May 7th, 2026|Chemistry World|
How Digital Access Is Reshaping the Way Patients Choose Specialized Carenews2026-05-07T13:30:48+00:00May 7th, 2026|Medical Device News Magazine|
Atara, Pierre Fabre’s cell therapy to get another shot at FDA approvalnews2026-05-07T13:17:55+00:00May 7th, 2026|Endpoints News|
Rapid Medical™’ Reports TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findingsnews2026-05-07T12:51:10+00:00May 7th, 2026|Medical Device News Magazine|
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practicenews2026-05-07T12:46:30+00:00May 7th, 2026|Medical Device News Magazine|